0001140361-18-028738.txt : 20180615 0001140361-18-028738.hdr.sgml : 20180615 20180615124749 ACCESSION NUMBER: 0001140361-18-028738 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180613 FILED AS OF DATE: 20180615 DATE AS OF CHANGE: 20180615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Esfandiari Javan CENTRAL INDEX KEY: 0001397402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35569 FILM NUMBER: 18901631 MAIL ADDRESS: STREET 1: 3661 HORSEBLOCK ROAD CITY: MEDFORD STATE: NY ZIP: 11763 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC. CENTRAL INDEX KEY: 0001092662 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880425691 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3661 HORSEBLOCK ROAD CITY: MEDFORD STATE: NY ZIP: 11763 BUSINESS PHONE: (631) 924-1135 MAIL ADDRESS: STREET 1: 3661 HORSEBLOCK ROAD CITY: MEDFORD STATE: NY ZIP: 11763 FORMER COMPANY: FORMER CONFORMED NAME: Chembio Diagnostics Inc. DATE OF NAME CHANGE: 20040607 FORMER COMPANY: FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC DATE OF NAME CHANGE: 19990805 4 1 form4.xml FORM 4 X0306 4 2018-06-13 0001092662 CHEMBIO DIAGNOSTICS, INC. CEMI 0001397402 Esfandiari Javan 3661 HORSEBLOCK ROAD MEDFORD NY 11763 true Chief Science/Tech Officer Common Stock 2018-06-13 4 M 0 20000 5.64 A 111258 D Common Stock 2018-06-13 4 F 0 11345 D 99913 D Options to purchase common stock 5.64 2018-06-13 4 M 0 20000 0 D 2018-03-11 2021-03-11 Common Stock 20000 0 D The reporting person did not sell any shares of common stock. Rather, the reporting person exercised options to acquire 18,712 shares of common stock by submitting and relinquishing to the issuer (i) options to purchase an additional 1,288 shares of common stock and (ii) 10,057 shares of common stock. These additional options to purchase 1,288 shares of common stock and the 10,057 shares of common stock constituted the entire exercise price, using the 10-day volume weighted average trading price ended June 12, 2018 of $9.9432. As a result of these transactions, the reporting person increased his common stock ownership by a net addition of 8,655 shares. /s/ Javan Esfandiari 2018-06-15